BCRX  Biocryst Pharmaceuticals Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

407.88B

Vuru Grade

23.50/100

Current Price

$5.53
-0.11 (-1.95%)

Company Metrics

  • P/E 0
  • P/S 18933
  • P/B 104.44
  • EPS -0.94
  • Cash ROIC -251.78%
  • Cash Ratio 0.80
  • Dividend 0 / 0%
  • Avg. Vol. 796,756.00
  • Shares 72.90M
  • Market Cap. 407.88B

Company Description

BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to develop new therapeutic candidates. The com... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Focusing on the Charts for BioCryst Pharmaceuticals Inc. (BCRX)
Yankee Analysts - 1 hour ago
Keeping an eye on moving averages for BioCryst Pharmaceuticals Inc. (BCRX), the 50-day is 4.84, the 200-day is at 3.74, and the 7-day is 5.5.
Technical Action Update on Shares of BioCryst Pharmaceuticals Inc. (BCRX) - MicroCap Wired
BioCryst Pharmaceuticals Inc Risk Points versus Health Care
CML News - Dec 6, 2016
This is a scatter plot analysis of the critical risk points from the option market for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) compared to its own past and the Health Care ETF.
The BioCryst Pharmaceuticals Inc. (BCRX) Set to Announce Quarterly Earnings on ...
DailyQuint - Dec 6, 2016
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) will issue its Q316 quarterly earnings data on Monday, November 7th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $5.94 million for the quarter.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Bearish Target At $10 - Stock Observer
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Reported Comprehensive Income Of ... - Enterprise Leader
Investor Circle: Watching the Numbers on Shares of BioCryst Pharmaceuticals ...
Wall Street Lion - 3 hours ago
Traders and investors tracking shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) may be examining the company's FCF or Free Cash Flow.
Brokerages Set BioCryst Pharmaceuticals Inc. (BCRX) Target Price at $6.71
The Cerbat Gem - Dec 1, 2016
BioCryst Pharmaceuticals logo BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has earned a consensus rating of “Buy” from the ten brokerages that are presently covering the stock.
Today: Analysts give average Rating of “Buy” to BioCryst Pharmaceuticals Inc ... - DailyQuint
Checking on Levels for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Liberty News - 4 hours ago
Value investors may be interested in the Magic Formula (MF Rank) on shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX).
Performance Update for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
The Newburgh Press - Nov 8, 2016
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has a 1 Year Target Estimate of $6.33. The stock traded with the volume of 1.62 Million in the last trading session.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Delivers a Better-Than-Expected ... - Scibility Media
BioCryst Pharmaceuticals Inc. (BCRX) Stock Rating Reaffirmed by HC Wainwright - The Cerbat Gem
FY2016 Earnings Estimate for BioCryst Pharmaceuticals Inc. (BCRX) Issued By ...
The Cerbat Gem - Nov 11, 2016
BioCryst Pharmaceuticals logo BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) - Jefferies Group boosted their FY2016 earnings per share estimates for BioCryst Pharmaceuticals in a research note issued on Monday.
FY2016 EPS Estimates for BioCryst Pharmaceuticals Inc. Boosted by FBR & Co (BCRX) - Community Financial News
Biotech Names On Frontline: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX ... - TWN
Today, The Brokerages Set BioCryst Pharmaceuticals Inc. (BCRX) Target Price at ...
DailyQuint - Dec 5, 2016
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has been assigned an average recommendation of “Buy” from the ten brokerages that are covering the stock.
What Smart Money Thinks about BioCryst Pharmaceuticals, Inc. (BCRX)? - Insider Monkey (blog)
Take a look at Price Moves: Akorn, Inc. (NASDAQ:AKRX) , BioCryst ... - Street Updates
BioCryst Pharmaceuticals Inc. (BCRX) Soars 6.47% on December 02
Equities.com - Dec 2, 2016
BioCryst Pharmaceuticals Inc. (BCRX) had a good day on the market for Friday December 02 as shares jumped 6.47% to close at $5.51.